Dialysis Corporation of America Announces the Development of Two New Facilities in...

Dialysis Corporation of America Announces the Development of Two New
Facilities in Ohio

LINTHICUM, Md., March 30 /PRNewswire-FirstCall/ -- Dialysis Corporation of
America (Nasdaq: DCAI) announced the development of two new facilities in
Cincinnati, Ohio, through an affiliation with the University of Cincinnati,
School of Medicine, to be located in the greater Cincinnati area.

President & CEO Stephen Everett commented, "These two new centers will serve
as further expansion of our relationship with an outstanding group of
physicians and University which serve more than 450 ESRD patients in and
around Cincinnati. Our first center with these nephrologists is located in the
Norwood area of Cincinnati and currently cares for approximately 60 patients.
These new centers will be our sixth and seventh in Ohio, and in line with
DCA's overall development strategy."

The centers will offer state-of-the-art equipment and technology, be designed
with patient comfort in mind, and include 15 to 18 treatment stations, along
with a Peritoneal Suite for patients opting for that modality.

Dialysis Corporation of America owns and operates freestanding kidney
hemodialysis centers located in Georgia, Maryland, New Jersey, Ohio,
Pennsylvania, South Carolina, and Virginia, and provides in-hospital dialysis
services on a contract basis to certain hospitals located in the those states.
The company provides patients with their choice of a full range of quality
in-center, acute or at-home hemodialysis services.

This release contains forward-looking statements that are subject to risks and
uncertainties that could affect the business and prospects of the company and
cause actual results and plans to differ materially from those anticipated.
Those factors include, but are not limited to, increases in interest rates,
the possible need for and availability of additional financing, the company's
satisfying the covenants and conditions of its credit facility, certain delays
beyond the company's control with respect to future business events, the
highly competitive environment in the establishment and operation of dialysis
centers, the ability to develop or acquire additional dialysis facilities,
whether patient bases of the company's dialysis facilities can mature to
provide profitability, the extensive regulation of dialysis operations,
government rate determination for Medicare reimbursement, pricing pressure
from private payors, and other risks detailed in the company's filings with
the SEC, particularly as described in the company's annual report on Form 10-K
for the fiscal year ended December 31, 2008. The historical results contained
in this press release are not necessarily indicative of future performance of
the company.

Other Dialysis Corporation of America press releases, corporate profile,
corporate governance materials, quarterly and current reports, and other
filings with the Securities and Exchange Commission are available on Dialysis
Corporation of America's internet home page:
http://www.dialysiscorporation.com.

SOURCE Dialysis Corporation of America

Dialysis Corporation of America, Investor Relations, +1-410-694-0500